Skip to content
Search

Latest Stories

Independent economic analysis will not be published before contract announcement, says NHSE

Independent economic analysis will not be published before contract announcement, says NHSE

Pharmacy minister Stephen Kinnock


The independent economic analysis of pharmacy finances will not be published before a new funding contract has been announced despite calls for the immediate release of the review.


Last week, pharmacy minister Stephen Kinnock said the final report was “nearing completion”.

However, whilst it has been shared with both the government and Community Pharmacy England (CPE), NHS England national director for primary care Dr Amanda said there are no plans for any imminent updates.

Doyle added that NHSE had agreed with CPE “not to comment publicly on anything related to the uplift or funding arrangements for the sector given we remain in consultation”.

Last month, Health and Social Care Committee (HSCC) chair Layla Moran wrote to Doyle asking for the report to be published “immediately”.

The National Pharmacy Association (NPA) and the Independent Pharmacies Association (IPA) also wrote to NHSE, demanding the immediate release of the report that was commissioned last autumn.

An open letter, signed by the owners of 3,034 pharmacies in England, calls for transparency on the funding gap amid ongoing contract negotiations.

The associations argued that withholding this analysis conceals the true extent of the sector’s financial plight from contractors and parliamentarians.

“We believe publishing this analysis now will help Ministers, the NHS and pharmacies chart a way to securing the stable and sustainable pharmacy network that our patients so desperately need,” they wrote.

NPA Chair Nick Kaye echoed these concerns, stating that the analysis would expose “the true and devastating extent to which funding for community pharmacy falls short.”

“The hundreds of pharmacy owners signing the open letter agree with us that pharmacies, patients and the public’s representatives in parliament should be allowed to see this vital information without further delay.

“There is no justification for the public to be kept in the dark on an issue of such national significance,” he added.

Doyle said that NHSE was committed to publishing the report in full but added: “we will publish the economic analysis report with the outcome of the (pharmacy contract) consultation”.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less